Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Norgestimate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Norgestimate [combined oc] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol + estradiol + norgestimate 1mg/1mg/0.09mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl estradiol + norgestimate 0.035mg/0.25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ethinylestradiol and norgestimate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol+norethisterone 35micrograms/1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norgestimate 215 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 215 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 215 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norgestimate 215 microgram oral tablet |
Has precise active ingredient |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
Has precise active ingredient |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
Has precise active ingredient |
False |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol and norgestimate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only norgestimate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
Has precise active ingredient |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
Has precise active ingredient |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norgestimate 215 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norgestimate 215 microgram oral tablet |
Has precise active ingredient |
True |
Norgestimate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |